Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Endocrinology

Symptoms and Warning Signs: When Bone Loss Isn't Silent

At a Glance

Drug-induced osteoporosis often causes no symptoms until a minor injury leads to a fracture. Unexplained height loss, a rounded back, persistent back pain, or sudden weakness, numbness, and bowel or bladder changes should prompt medical assessment.

Drug-induced osteoporosis is often called a silent disease because bone loss itself does not cause symptoms [1]. You cannot feel your bones thinning as you take medications like steroids or aromatase inhibitors. For many people, the very first sign that their medication has affected their bones is a fragility fracture—a broken bone (like the wrist, hip, or pelvis) caused by a minor event that would not normally cause an injury, such as a sneeze, a cough, or a small trip from a standing height [2][3].

The Signs of ‘Silent’ Spine Fractures

While some fractures are sudden and painful, many vertebral compression fractures (breaks in the bones of the spine) happen gradually and without a clear injury [4]. In fact, vertebral fractures can sometimes be painless or cause only diffuse aching. Only about one-third of these fractures are recognized when they first occur [1]. Over time, these small “micro-fractures” can cause your spine to collapse slightly, leading to symptoms you might mistake for general aging or muscle strain:

  • Unexplained Height Loss: This is one of the most reliable indicators of a silent spinal fracture [5]. Doctors generally consider a loss of 1.5 inches (4 cm) or more over your lifetime—or 0.8 inches (2 cm) within a single year—as a trigger for specialized spine imaging [6].
  • Postural Changes: You may notice a new or worsening rounding in your upper back (hyperkyphosis). This happens as the front of the vertebrae weakens and compresses into a wedge shape [7][2].
  • Dull, Aching Back Pain: Chronic, nagging pain in the middle or lower back that worsens when standing or walking and feels better when lying down can be a sign of a healing or stable compression fracture [2][3].

Is it a Fracture or a Medication Side Effect?

Some medications that cause bone loss also cause muscle or joint pain, making it difficult to know if you are experiencing a side effect or a new fracture. Symptoms alone cannot reliably diagnose the cause.

  • Aromatase Inhibitor (AI) Pain: AIs often cause arthralgia (joint pain) and stiffness, particularly in the hands, wrists, and knees [8]. While this pain is often symmetric (felt on both sides), it is not always predictable [8][9].
  • Steroid Myopathy: High-dose glucocorticoids can cause muscle weakness, especially in the hips and shoulders. You might find it difficult to stand up from a chair or climb stairs [10].
  • Fracture Pain: A fracture can cause sudden, sharp, focal pain that flares up sharply with specific movements like twisting or bending, but it can also present as a vague ache [3][2]. Because symptoms cannot reliably diagnose the cause, any new, persistent, sudden, or function-limiting back pain deserves clinical assessment.

Red Flags: When to Seek Urgent Care

An acute vertebral fracture can be an emergency, especially if the bone fragments press on your spinal cord or nerves. Seek immediate medical evaluation if you experience any of the following:

  1. Sudden, Severe Spine Pain: Pain that starts abruptly after a minor movement (like lifting a grocery bag or sneezing) and is so intense it prevents you from moving [2].
  2. Neurological Changes: New or worsening weakness in your legs, numbness or “pins and needles” in your lower body, or difficulty walking [11][12].
  3. Bowel or Bladder Changes: Any new loss of control over your bowels or bladder, or difficulty starting urination (urinary retention) [13][14].
  4. Saddle Anesthesia: Numbness or tingling in the “saddle area”—your groin, buttocks, or inner thighs [13].
  5. Fever and Back Pain: Severe back pain accompanied by fever, chills, or unexplained weight loss, which may indicate an infection or other serious underlying condition [15][16].

If you are taking high-risk medications, do not wait for a major fall to discuss bone health. Regular height checks and reporting even “mild” back pain to your care team are essential steps in catching bone loss before it changes your life [17][18].

Common questions in this guide

Can drug-induced osteoporosis cause symptoms before a fracture happens?
Bone thinning itself usually does not cause symptoms, so the first sign may be a fracture after a minor event. Spinal fractures can also develop gradually with little or no pain. New height loss, a rounded back, or persistent back pain should be discussed with a clinician.
What are the warning signs of a silent spinal fracture?
A silent spinal fracture may cause unexplained loss of height, a new or worsening rounded upper back, or dull aching pain in the middle or lower back. Some spinal fractures have no obvious injury or pain, so a clinician may recommend specialized spine imaging when height loss or other concerns are present.
How can I tell whether my pain is from an aromatase inhibitor or a fracture?
Symptoms alone cannot reliably identify the cause. Aromatase inhibitors commonly cause joint pain and stiffness, often in the hands, wrists, or knees, while a fracture may cause sudden focal pain or a vague backache that worsens with movement. New, persistent, or function-limiting pain needs clinical assessment.
When does back pain from possible osteoporosis require emergency care?
Seek immediate medical evaluation for sudden severe spine pain, new leg weakness or numbness, difficulty walking, loss of bowel or bladder control, trouble urinating, or numbness in the groin, buttocks, or inner thighs. Severe back pain with fever, chills, or unexplained weight loss also needs urgent assessment.
How much height loss may lead to testing for a silent spinal fracture?
Clinicians may consider specialized spine imaging after a lifetime height loss of about 1.5 inches or 4 centimeters, or a loss of about 0.8 inches or 2 centimeters in one year. Your care team will decide whether a vertebral fracture assessment or spinal X-ray is appropriate.
Do I need medical follow-up if a fracture causes little or no pain?
Yes. Vertebral fractures can be painless or cause only mild aching, but they still indicate weakened bones and may affect your future fracture risk and osteoporosis care. Contact your care team so they can assess the fracture and review your treatment plan.

Get notified when new evidence is published on drug-induced osteoporosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    Epidemiology of Vertebral Fractures.

    Schousboe JT

    Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2016; (19(1)):8-22.

    PMID: 26349789
  2. 2

    Diagnosis and Management of Vertebral Compression Fractures.

    McCarthy J, Davis A

    American family physician 2016; (94(1)):44-50.

    PMID: 27386723
  3. 3

    Managements of osteoporotic vertebral compression fractures: A narrative review.

    Patel D, Liu J, Ebraheim NA

    World journal of orthopedics 2022; (13(6)):564-573 doi:10.5312/wjo.v13.i6.564.

    PMID: 35949707
  4. 4

    Spine fracture prevalence in a nationally representative sample of US women and men aged ≥40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014.

    Cosman F, Krege JH, Looker AC, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2017; (28(6)):1857-1866 doi:10.1007/s00198-017-3948-9.

    PMID: 28175980
  5. 5

    Development of prediction model for osteoporotic vertebral compression fracture screening without using clinical risk factors, compared with FRAX and other previous models.

    Chanplakorn P, Lertudomphonwanit T, Daraphongsataporn N, et al.

    Archives of osteoporosis 2021; (16(1)):84 doi:10.1007/s11657-021-00957-y.

    PMID: 34085107
  6. 6

    Repeating Vertebral Fracture Assessment: 2019 ISCD Official Position.

    Borges JLC, Sousa da Silva M, Ward RJ, et al.

    Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2019; (22(4)):484-488 doi:10.1016/j.jocd.2019.07.005.

    PMID: 31375350
  7. 7

    Capture the vertebral fracture: Risk factors as a prediction.

    Zvekic-Svorcan J, Aleksic J, Jankovic T, et al.

    Journal of back and musculoskeletal rehabilitation 2019; (32(2)):269-276 doi:10.3233/BMR-170898.

    PMID: 30347589
  8. 8

    Aromatase Inhibitor-Associated Distal Radioulnar Joint Instability and Tear of the Extensor Digiti Minimi: A Case Report.

    Holt J, Salas M, Lee SW

    American journal of physical medicine & rehabilitation 2024; (103(7)):e86-e89 doi:10.1097/PHM.0000000000002456.

    PMID: 38466152
  9. 9

    Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort study.

    Pineda-Moncusí M, Servitja S, Tusquets I, et al.

    Breast cancer research and treatment 2019; (177(1)):53-60 doi:10.1007/s10549-019-05289-7.

    PMID: 31127467
  10. 10

    Musculoskeletal involvement: COVID-19 and post COVID 19.

    Evcik D

    Turkish journal of physical medicine and rehabilitation 2023; (69(1)):1-7 doi:10.5606/tftrd.2023.12521.

    PMID: 37201006
  11. 11

    Metastatic Spinal Cord Compression: Unraveling the Diagnostic and Therapeutic Challenges.

    Boussios S, Cooke D, Hayward C, et al.

    Anticancer research 2018; (38(9)):4987-4997 doi:10.21873/anticanres.12817.

    PMID: 30194142
  12. 12

    The Management of Pelvic and Vertebral Fragility Fractures: An Unmet Care Need.

    Anderson PA, Giangregorio LM, Routt MLC

    The Journal of bone and joint surgery. American volume 2026; doi:10.2106/JBJS.26.00966.

    PMID: 42758781
  13. 13

    Assessment and early investigation of cauda equina syndrome- a systematic review of existing international guidelines and summary of the current evidence.

    Hennessy O, Devitt AT, Synnott K, Timlin M

    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 2025; (34(4)):1545-1551 doi:10.1007/s00586-025-08732-0.

    PMID: 40000448
  14. 14

    Cauda equina syndrome: a structured approach for the higher orthopaedic examination.

    Pammi S, Rajan P, Narapareddy H

    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie 2026; (36(1)).

    PMID: 42709243
  15. 15

    Red Flags for Low Back Pain Are Not Always Really Red: A Prospective Evaluation of the Clinical Utility of Commonly Used Screening Questions for Low Back Pain.

    Premkumar A, Godfrey W, Gottschalk MB, Boden SD

    The Journal of bone and joint surgery. American volume 2018; (100(5)):368-374 doi:10.2106/JBJS.17.00134.

    PMID: 29509613
  16. 16

    Thoracic Pyogenic Spondylitis Misdiagnosed As Osteoporotic Compression Fracture Status Post Vertebral Augmentation With Resultant Paraplegia: A Case Report.

    Chen PW, Liu PC, Lee CC, Lam CT

    Cureus 2024; (16(6)):e63497 doi:10.7759/cureus.63497.

    PMID: 39081447
  17. 17

    2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

    Humphrey MB, Russell L, Danila MI, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2023; (75(12)):2088-2102 doi:10.1002/art.42646.

    PMID: 37845798
  18. 18

    Making VFA Part of Standard Clinical DXA Assessment for Osteoporosis Care: Recommendations From the International Working Group on DXA Best Practices.

    Lems WF, Ward KA, Lewiecki EM, et al.

    Mayo Clinic proceedings 2025; (100(12)):2186-2205 doi:10.1016/j.mayocp.2025.08.005.

    PMID: 41338753

This page is for informational purposes only and does not constitute medical advice. It explains warning signs of drug-induced osteoporosis, but a clinician must assess new or persistent pain and possible fractures; seek urgent care for neurological or bowel or bladder changes.

Guide contents drug-induced osteoporosis
Research & Literature
01 Medications That Weaken Bone 03 Diagnosis and Screening